Susan Swedo, M.D.

Name, Degree: Susan E. Swedo, M.D.
Role(s) in Task Force and Work Group: Chair, Neurodevelopmental Disorders Work Group
Institutional Affiliation(s): National Institute of Mental Health
City, State: Bethesda, MD

Biographical Sketch:

Dr. Susan Swedo received her M.D. from Southern Illinois University School of Medicine and completed a pediatrics residency at Children’s Memorial Hospital in Chicago.  Dr. Swedo served as Chief of Adolescent Medicine for Northwestern University until 1986, when she joined Dr. Judy Rapoport’s laboratory at the National Institute of Mental Health (NIMH).  There, she earned scientific tenure and now leads the Pediatrics and Developmental Neuropsychiatry Branch (PDN), which conducts research on the causes and treatment of pediatric neuropsychiatric disorders, including obsessive-compulsive disorder (OCD), anxiety disorders, and autistic spectrum disorders.  Dr. Swedo and her colleagues were the first to identify a post-infectious subtype of OCD, which is known as PANDAS (pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections).  This line of research has resulted in several novel treatment and prevention strategies for childhood-onset OCD, as well as a patent for a biological marker that can be used to identify at-risk children.  The recipient of numerous awards, including the American Academy of Child and Adolescent Psychiatry Award for Scientific Achievement and the American College of Neuropsychopharmacology International Award for Clinical Research, Dr. Swedo is the author of more than 100 professional books and articles.  She is also the co-author with Dr. Henrietta Leonard of two trade books:  It’s Not All In Your Head and Is It Just a Phase? - a parent’s guide to childhood behavioral problems.

Uncompensated affiliations with non-profit or advocacy organizations that may have a direct or indirect interest in psychiatric diagnosis, treatment, or the DSM-V :   Three calendar years before  nomination and Each year thereafter through the present calendar year.  (For 2008, activities to date and commitments for remainder of year.)

Non-Profit and Advocacy Organizations

Year(s)

Role

Trichotillomania Learning Center (TLC)

2000-2004

Scientific Advisory Board

Anxiety Disorders Association of America

1998-2003

Scientific Advisory Board


The two tables below represent Dr. Susan Swedo’s disclosure of significant interests and affiliations for:  (1) The time period including the 3 years prior to nomination to serve on the DSM-V Task Force; the calendar year in which nomination to the Task Force occurred; through the calendar year in which the nomination was approved; and (2) the time period including the calendar year after approval, and each successive year to the present.

Dr. Susan Swedo has agreed that, from the time of approval through the publication of DSM-V, projected in 2012, her aggregate annual income derived from industry sources (excluding unrestricted research grants) will not exceed $10,000 in any calendar year.

KEY NUMBER:
1. Consultation Fees  (include scientific advisory boards)
2. Full- or Part-time Employee
3. Industry-related Grant-Research Support received or pending
4. Honoraria (includes Speakers’ Bureau)
5. Stock or other financial options 

6. Expert testimony
7.  Royalties (including right to share of revenue or profit from pharmaceutical, device or other development or product)
8. Patents received or pending
9. Officer, director/trustee, executive (specify)
10.  Other  (specify)


Disclosure of significant interests including:  Three (3) calendar years before nomination, the calendar year of nomination, through the calendar year of approval to serve on the DSM-V Task Force

Commercial or Other Organization

Year(s)

Key #(s)

None

 

 


Disclosure of significant interests Beginning with the calendar year after APA Board of Trustees approval to serve on  the DSM-V Task Force, to the present. 
(For 2008, activities to date and commitments for remainder of year.)

Commercial or Other Organization

Year(s)

Key #(s)

None

 

 

From: 
Email:  
To: 
Email:  
Subject: 
Message: